An exosome-based liquid biopsy predicts depth of response and survival outcomes to cetuximab and panitumumab in metastatic colorectal cancer: The EXONERATE Study.
Xu C, Mannucci A, Esposito F, Oliveres H, Alonso Orduña V, Yubero A, Fernández-Martos C, Salud A, Gallego J, Martin-Richard M, Fernández-Plana J, Guillot M, Aparicio J, Fakih M, Kopetz S, Feliu J, Maurel J, Goel A.
Xu C, et al.
Clin Cancer Res. 2025 Jan 17. doi: 10.1158/1078-0432.CCR-24-1934. Online ahead of print.
Clin Cancer Res. 2025.
PMID: 39820673